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Abstract: Deciphering conformational dynamics is crucial for 
understanding the biological functions of proteins and for designing 
compounds targeting them. In particular, providing an accurate 
description of µs-ms motions opens up the opportunity for regulating 
protein-protein interactions (PPIs) by modulating dynamics of one 
interacting partner. Here we analyzed the conformational dynamics 
of prolyl oligopeptidase (POP) and the effects of active site-directed 
inhibitors on the dynamics. For this purpose, we used an integrated 
structural biology approach based on NMR spectroscopy and SAXS 
experiments complemented by MD simulations. Our results found 
that POP is in a slow equilibrium in solution between open and 
closed conformations, and that inhibitors effectively prevented this 
equilibrium by stabilizing the enzyme in a closed conformation. 
Dynamics is an essential component for the biological functions 
of proteins.[1] Therefore, the characterization of protein motions 
is fundamental for developing therapeutic compounds that may 
modulate conformational dynamics of their targets. Considering 
the emergent therapeutic focus on protein-protein interactions 
(PPIs),[2] modulating µs-ms dynamics opens up a valuable 
opportunity for regulating the affinity and specificity of 
recognition between flexible proteins.[3] Hence, the design of 
compounds that modify conformational dynamics stand as a 
promising strategy for controlling PPI networks involved in 
pathogenic mechanisms. 
Prolyl Oligopeptidase (POP) is an 81-KDa monomeric serine 
peptidase that hydrolyzes short peptides at the carboxyl side of 
proline.[4] The structure of POP is divided in two domains, 
namely α/β-hydrolase and the β-propeller, which are linked by a 
pair of hinge polypeptide chains. X-ray structures of the 
mammalian enzyme shows that the α/β-hydrolase and β-
propeller are packed together in a closed conformation (Figure 1 
A).[5] However, the crystallization of two bacterial POPs showing 
a large-scale hinge separation between domains[6] (Figure 1 B) 
suggested that the mammalian enzyme might undergo 
interdomain flexibility.[7] In this direction, two studies based on 
15N line broadening NMR experiments[8] and X-ray 
crystallography combined with MD simulations[9] strongly 
supported that POP is a highly flexible enzyme, but several 
fundamental aspects concerning the conformational landscape 
of POP in solution and the effects of inhibitors are largely 
unknown. 
 
Figure 1. A) Porcine POP in the closed conformation (PDB ID: 1QFS[5]), 
covalently bound to the active site-directed inhibitor ZPP (orange). The α/β-
hydrolase is shown in green and the β-propeller in blue. B) Aeromonas 
punctata POP in the open conformation (PDB ID: 3IUJ[6a]), colored following 
the same code as in A). C) Chemical structures of ZPP and KYP-2047 
inhibitors.  
The in vivo role of POP is related to synaptic functions and 
neuronal development. In this regard, it has been found that 
POP interacts with the intrinsically disordered proteins α-
synuclein and GAP-43.[10] Recent studies have demonstrated 
that the direct interaction between POP and α-synuclein, the 
protein involved in the development of Parkinson’s disease, 
accelerates the aggregation of α-synuclein in vitro and in cells.[11] 
Interestingly, KYP-2047,[12] a covalent active site-directed 
inhibitor of POP (Figure 1 C) effectively reduce aggregation in 
vitro and in vivo.[11a, 13] Further experiments have shown that this 
reduction is a consequence of an increased in vivo clearance of 
aggregated forms of α-synuclein promoted by POP inhibition.[13b] 
[a] Dr. A. López, Dr. T. Tarragó, Prof. E. Giralt 
Chemistry and Molecular Pharmacology Program 
Institute for Research in Biomedicine, The Barcelona Institute of 
Science and Technology 
Baldiri Reixac 10, 08028, Barcelona, Spain 
E-mail: ernest.giralt@irbbarcelona.org 
[b] Dr. A. López, Prof. E. Giralt 
 Department of Organic Chemistry 
 University of Barcelona 
 Martí i Franquès, 1-11, 08028, Barcelona, Spain 
[c] F. Herranz-Trillo, Dr. Pau Bernadó 
Centre de Biochimie Structurale 
INSERM U1054, CNRS UMR 5048, Université de Montpellier 1 and 
2 
29 rue de Navacelles, 34090, Montpellier, France 
[d] Dr. M. Kotev, Dr. V. Guallar 
Joint BSC-CRG-IRB Research Program in Computational Biology 
Barcelona Supercomputing Center 
Jordi Girona 31, 08034, Barcelona, Spain 
[e] Dr. M. Gairí 
NMR Facility 
Scientific and Technological Centers University of Barcelona 
(CCiTUB) 
Baldiri Reixac 10, 08028, Barcelona, Spain 
[f] Dr. V. Guallar 
Institució Catalana de Recerca i Estudis Avançats (ICREA) 
Passeig Lluís Companys 23, 08010, Barcelona, Spain 
[g] Dr. O. Millet 
Structural Biology Unit 
CIC bioGUNE 
Parque Tecnológico de Vizcaya, Ed. 800, 48160 Derio, Spain 
[h] Dr. T. Tarragó 
 Iproteos, S L 
Barcelona Science Park, Baldiri Reixac 10, 08028, Barcelona, Spain 
 Supporting information for this article is given via a link at the end of 
the document. 
COMMUNICATION          
 
 
 
 
Nevertheless, the lack of knowledge on the conformational 
dynamics of POP and the effects of inhibitors represents a major 
impediment for exploring the mechanisms underlying POP-
mediated aggregation of α-synuclein. For this reason, here we 
have analysed in detail the conformational equilibrium of POP in 
solution and how it is affected by the binding of active-site 
directed inhibitors. For this purpose, we have combined the 
capacity of NMR spectroscopy to describe dynamic events at 
atomic resolution[14] with the potential of SAXS experiments 
complemented with MD simulations to probe large-scale 
structural fluctuations in solution.[15] 
Conformational dynamics of POP in the time scale of µs-ms was 
analyzed by methyl-TROSY 13C-1H multiple quantum relaxation 
dispersion (RD) experiments[16] using selective labeling of methyl 
positions of methionine residues.[17] Methionine methyl groups 
are excellent reporters of structure and dynamics due to 
simplified spectra and the high sensitivity and resolution 
achieved using the TROSY effect.[18] To assign the methyl-
TROSY spectrum, we took site-directed mutagenesis approach 
(see Supporting Information). In order to eliminate the 
contribution of dipolar relaxation from surrounding protons in the 
effective transverse relaxation rates (R2,eff),[16, 18] we produced a 
highly deuterated [methyl-13C]-methionine-labeled POP. For this 
purpose, methionine auxotrophic E.coli cells were supplemented 
with [methyl-13C]-L-methionine (2, 3, 3, 4, 4, - d5) in a highly 
deuterated expression medium. This methionine isotopomer was 
chemically synthesized in order to achieve high deuterium 
content in non-labeled positions, especially in β and γ positions 
(see Supporting Information). Interestingly, RD experiments of 
free POP showed intense decay curves for most methionine 
signals (Figure 2, red), providing robust signatures for the 
pervasive µs-ms dynamics of the free enzyme. Estimated values 
of the exchange parameters were extracted by fitting the RD 
data to a two-state mode.l[16] kex values obtained from fitting of 
RD data were comprised between 38 s-1 to 167 s-1, with a 
population between exchanging states around 50% (Table 1). 
Figure 3 A shows that highest amplitude motions were localized 
in the α/β-hydrolase domain. 
Afterwards, the effects of binding of the covalent active site-
directed inhibitors benzyloxycarbonyl-prolyl-prolinal (ZPP, Figure 
1 C)[19] and KYP-2047 on POP conformational dynamics were 
examined. Extensive changes in the methyl-TROSY spectra of 
inhibited POP indicated large-scale conformational 
rearrangements upon inhibitor binding, which predominantly 
affected the α/β-hydrolase (Figures 3 B and S3). Remarkably, 
RD experiments of inhibited POP revealed that inhibition caused 
dramatic effects in µs-ms dynamics. The decay in the RD 
profiles of methionine residues was effectively abolished (Figure 
2, blue), indicating that the binding of inhibitors totally prevented 
the conformational dynamics of POP. 
 
Figure 2. Multiple quantum RD experiments of highly deuterated [methyl-13C]-
methionine-labeled POP. RD profiles of methionine residues of free POP and 
ZPP-bound POP are shown in red and blue, respectively; solid lines 
correspond to the best fits of the data to a two-state model. 
   
Table 1. Summary of exchange parameters of free POP extracted from 
the fitting of multiple quantum RD data. 
Methionine kex (s-1) pB (%)  Methionine kex (s-1) pB (%) 
156 45 ± 7 49  581 52 ± 18 46 
176 50 ± 9 49  633 50 ± 13 50 
452 38 ± 11 51  696 112 ± 14 47 
495 167 ± 21 45     
   
In order to unravel the structural aspects of the conformational 
dynamics of POP and the effects of inhibitor binding, we used 
SAXS, a highly versatile technique that probes molecular 
structure at low resolution in solution.[15] Free and ZPP-bound 
POP samples were analyzed using an online gel filtration 
chromatography coupled to SAXS in order to eliminate the 
interference of protein aggregates (Figure S4 in the Supporting 
Information). In the two cases, scattering profiles of eluted 
monomer species presented high spectral homogeneity as 
determined by singular value decomposition (see Supporting 
Information). Subsequently, these profiles were averaged to 
obtain the corresponding high-quality scattering profiles, which 
showed no signatures of interparticle interactions or radiation 
damage (see Figures 4 A and S5 in the Supporting Information). 
Afterwards, the overall size of particles in solution was evaluated 
by extracting the radius of gyration (Rg). Comparison of Rg of 
free and inhibited POP disclosed significant structural 
differences between the two forms of the enzyme (Rg of 28.50 ± 
0.06 Å vs. 27.40 ± 0.06 Å, respectively). In turn, the pair-
distance distribution functions (P(r) Figure 4 B) of free and 
inhibited POP revealed significant differences in the global 
shape. P(r) function of free POP yielded a multimodal 
distribution with a maximum dimension (Dmax) of 86 ± 3 Å, while 
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ZPP-bound POP showed a Gaussian-like distribution of smaller 
Dmax (81 ± 3 Å). 
 
Figure 3. A) Structure distribution of ΔRex values obtained by multiple 
quantum RD experiments of free POP. B). Assigned methyl-TROSY spectrum 
of free POP (red) overlaid with the spectra of POP bound to ZPP (blue) and of 
POP bound to KYP-2047 (green). Enlarged view of the boxed region shows 
that the signal of methionine 235 (marked with an asterisk) is strongly 
sensitive to the binding of active site-directed inhibitors. 
To ultimately assess the conformational equilibrium of POP and 
the structural consequences of inhibitor binding, we took 
advantage of the ensemble optimization method (EOM),[20] a 
procedure that optimizes a sub-ensemble of structures from a 
large pool of model structures using the experimental scattering 
profile as a driving force. To obtain a large pool of models 
sampling a broad conformational space, we performed MD 
simulations starting from the crystallographic structure of POP in 
the closed conformation and the porcine homology model of 
Aeromonas punctata POP in the open conformation (see 
Supporting Information). Hence, the EOM of free and ZPP-
bound POP provided sub-ensembles of conformations that 
collectively described the experimental scattering profiles with 
excellent fit (Figures 4 A and S6 in the Supporting Information). 
Structures of free POP selected by the EOM consisted of 55% of 
fully open and 45% of closed conformations (Figure 4 C, red). 
These conformational populations are in agreement with those 
extracted from the fitting of RD data, providing a cross-validation 
between the two approaches. Theoretical averaged Rg of 
selected open structures was 30.50 ± 0.08 Å, whereas in the 
closed structures this value was 27.35 ± 0.07 Å, being fully 
compatible with the experimental Rg of free POP (28.50 ± 0.06 
Å). In contrast, selected structures of POP bound to ZPP 
consisted exclusively of closed conformations resembling the X-
ray structure of POP covalently bound to ZPP (Figure 4 C, blue). 
Theoretical averaged Rg of selected structures of inhibited POP 
also was in good agreement with the experimental value (Rg 
values of 27.23 ± 0.01 Å vs. 27.40 ± 0.06 Å, respectively). 
 
Figure 4. SAXS experiments of free and inhibited POP. A) Averaged 
scattering profiles of free POP (red) and ZPP-bound POP (blue). Insets show 
Rg values and Guinier plots, which confirms the absence of interparticle 
interactions and radiation damage. The theoretical scattering profile obtained 
by the EOM is shown in black. B) P(r) distribution of free POP (red) and ZPP-
bound POP (blue). Dotted lines shows the corresponding maximum 
dimensions (Dmax), which reflects the bigger size of free POP. C) Structures of 
POP selected by the EOM. Representative open and closed structures of free 
POP are shown in red, and representative closed conformation of POP 
covalently bound to ZPP is shown in blue; inhibitor is marked by a black circle. 
In summary, the integrated approach combining NMR 
spectrometry and SAXS experiments complemented by MD 
simulations have demonstrated that POP is a highly dynamic 
enzyme in the ms time scale, showing an equilibrium between 
open and closed conformations. In turn, we have shown that the 
binding of active site-directed inhibitors effectively impedes the 
conformational exchange by stabilizing POP in a closed 
conformation. According to these results, it can be therefore 
proposed that µs-ms conformational dynamics of POP causes 
significant fluctuations in the configuration of the surface(s) 
involved in molecular recognition events. Hence, stabilizing the 
POP in a closed conformation by inhibitors would cause 
substantial alterations on the affinity and specificity of the native 
PPIs of the enzyme. We speculate that this mechanism could 
represent a central feature for the reversibility of POP-mediated 
aggregation of α-synuclein induced by active site-directed POP 
inhibitors which has been reported in the literature.[11, 13] Overall, 
the results presented here open the way for designing novel 
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POP inhibitors conceived as conformational modulators able to 
regulate the native interactome of the enzyme. 
Experimental Section 
Cells were purchased from Novagen, chemicals from Sigma-Aldrich, and 
deuterated chemicals from Cambridge Isotope Laboratories. Affinity and 
size exclusion chromatography columns were from GE Healthcare Life 
Sciences. 
Expression of POP and [methyl-13C]-methionine-labeled POP: POP 
was expressed in Escherichia coli BL21 (DE3) cells using pET-11 
plasmid containing the human POP gene, following a standard 
protocol.[21] HisTag was removed by digestion with TEV protease, and 
POP was purified in a Superdex 200 HiLoad column before performing 
the experiments. For the [methyl-13C]-methionine-labeled POP, 
auxotrophic E. coli B834(DE3) cells were grown in minimal media 
containing 80 mg/l of [methyl-13C]-L-methionine. Purification was 
performed as described previously. In the case of highly deuterated 
[methyl-13C]-methionine-labeled POP, auxotrophic E.coli B834(DE3) cells 
were transformed with pETM-10 plasmid containing the human POP 
gene. Cells were grown in deuterated minimal medium supplemented 
with 2 g/l D-glucose (1, 2, 3, 4, 5, 6, 6 – d7) and 50 mg/l [methyl-13C]-L-
methionine (2, 3, 3, 4, 4, - d5), synthesized as described in the 
Supporting Information. HisTag cleavage was not performed in this case. 
The binding of ZPP and KYP-2047 inhibitors was carried out by drying an 
aliquot of 10 equivalents of the inhibitor dissolved in 1,4-dioxane with a 
soft stream of N2 in a small glass tube. Afterwards, POP sample was 
added to the tubes containing the dried inhibitor aliquot and incubated for 
20 min at room temperature. 
NMR experiments and fitting of RD data: All NMR experiments were 
performed at 25°C in a Bruker 800 MHz Avance III spectrometer 
equipped with a cryoprobe. POP samples comprised between 200 and 
250 µM in Tris d11-HCl 50 mM pH 8, NaCl 20 mM, DTT d6 1 mM, NaN3 
0.03%, and 100% D2O buffer. 1H-13C methyl-TROSY HMQC experiments 
used the pulse sequence described by Tugarinov et al.[18] Spectra 
comprised 128, 512 data points (F1, F2), with 240 scans per FID 
separated by an interscan delay of 1.5 s. 1H-13C methyl-TROSY HMQC 
RD experiments[16] used a CPMG element of 40 ms, with 0, 2, 4, 6, 8, 10, 
12, 16, 20, 24, 28, 32, 36 and 40 randomly ordered inversion pulses. 
Spectra were recorded using 100, 512 data points (F1, F2), accumulating 
24 scans separated by an interval of 1.5 s. Effective decay rates (R2,eff) 
were extracted from the major resonances using the following formula[22] 
(Equation 1): 
𝑅!,!"" 𝜗!"#$ = −1𝑇 ln 𝐼 𝜗!"#$𝐼!                      Equation  1  
Where T corresponds to the total transversal relaxation time (40 ms). The 
spectra of RD experiments were converted to NMRpipe format and 
processed with the NMRpipe software.[23] This equation was used to 
obtain the individual exchange contribution (kex) and the product Δω·pB 
that accounts for the population and the chemical shift of the second 
state (B), which is ultimately related to the amplitude of the motion. The 
fitting was performed considering each i methyl probe separately: 
ΔωHi, ΔωCi, kexi, pBi, R2MQ∞i (χ2i) 
Where Δω are the frequency differences between the 1H or 13C 
resonances of exchanging signals, pB is the population of the second 
state, and R2MQ∞ is the effective transverse relaxation at the fast pulsing 
limit. The global fitting, which considered the same kex and pB for all 
methyl groups, was performed by adjusting the spectral density of RD 
data by least-squares. The global fitting did not improve the results 
obtained by the independent one, as revealed by the F-test statistical 
analysis. 
The deconvolution of the product Δω·pB from a dataset obtained in a 
single static field was not statistically reliable. For this reason, several 
replicate fittings were performed in order to evaluate the reliability of the 
independent fitting. All replicates yielded highly reproducible results, 
which allowed the extraction of estimated values for Δω(13C) and pB 
separately. ΔRex values used to depict Figure 3 A were obtained as the 
difference between the theoretical R2,eff values at the low and the fast-
pulsing limit (R2∞). Given the absence of measurable exchange in the RD 
profiles of POP bound to ZPP and to KYP-2047, fitting was not 
performed in the case of inhibitor-bound POP. 
Online gel filtration coupled to SAXS: HisTag-cleaved samples of free 
and ZPP-bound POP were subjected to an online Superdex 200 10/300 
SEC column coupled to EMBL P12 beamline of the storage ring PETRA 
III (DESY, Hamburg), using a PILATUS 2M pixel detector (DECTRIS, 
Switzerland). The column was run at 0.35 ml/min, acquiring 1 frame per 
second. The X-ray beam wavelength was 1.24 Å, and the range of 
momentum transfer covered was 0.007 < s < 0.444 Å−1. The scattering 
profiles of all frames were inspected, and anomalous profiles were 
discarded. The scattering profiles corresponding to the pure buffer 
frames of free and ZPP-bound POP datasets were averaged and 
subsequently subtracted from all profiles using the PRIMUS program[24] 
(ATSAS data analysis software). The same program was used to 
average the subtracted scattering profiles of monomer species of free 
and inhibited POP, and to derive forward scattering (I(0)) and Rg from the 
Guinier approximation. P(r) distribution functions were obtained with the 
GNOM program.[25] 
Computational methods and ensemble optimization method (EOM): 
All free POP MD simulations were performed with AMBER12 software.[26] 
The ff99SB force field[27] for proteins was used, and explicit water 
molecules were incorporated as TIP3P water model.[28] Protein structures 
were neutralized and an additional number of sodium and chloride ions 
were added to simulate physiological saline solution. Protein plus ions 
were then solvated in pre-equilibrated water molecules in a truncated 
octahedron box with a 15 Å layer. After energy minimization, temperature 
was progressively raised to 300°K using constant pressure dynamics. All 
production runs were done with a time step of 2.0 fs in NPT ensemble (1 
bar and 298°K). The shorter MD simulation for ZPP-bound POP was 
computed using the Desmond molecular dynamics program.[29] The 
OPLS-AA force field and TIP3P water model were used.[28] The default 
relaxation protocol in Desmond was used, followed by the production run 
in the NPT ensemble. Prior to the EOM, theoretical scattering curves 
were calculated from the simulated PDB files using CRYSOL software 
(ATSAS data analysis software).[30] 
The EOM was performed over a sub-ensemble of N structures from a 
large pool of M model structures (M >> N) by minimizing the χ2 between 
the experimental (Iexp) and theoretical (Itheor) profiles (Equation 2): 
𝜒! = 1𝐾 − 1 𝜇𝐼!!!"# 𝑠! − 𝐼!"# 𝑠!𝜎 𝑠! !                       (Equation  2)!!!!  
Where K is the number of data points, σ(s) are the standard deviations, 
and µ is a scaling factor. Itheor,n(s) is defined from the individual n profiles 
as follows (Equation 3): 
𝐼!!!"# 𝑠 =    1𝑁 𝐼!!!"#,! 𝑠!!!!                     (Equation  3) 
Experimental curves used in the EOM comprised data points from s < 
0.15 Å-1 for POP, and from s < 0.3 Å-1 for POP bound to ZPP. Constant 
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subtraction was applied in all cases. The EOM was carried out using 50 
random initial sub-ensembles of N=20 structures, since the use of more 
structures in this method (N = 50) did not improve the result.[20] A total of 
1500 generations were performed. One hundred independent EOM runs 
were performed, and the most frequent result was taken as the solution 
with best fit (Figure 4 A). 
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